Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
ConferenceSeries International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, ConferenceSeries publishes 400 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals.
Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death. Most of the people begin to loss of muscle mass after age 30, but the loss of strength rise exponentially with age. The main effects of Sarcopenia are frailty, decreased muscle strength, weak bones, problems with mobility, decreased activity levels, falls and fractures, diabetes and loss of physical function and independence. Sarcopenia affects gait, balance and overall ability to perform tasks of daily living, are hallmark signs of this disease.
The main factors for Sarcopenia are decrease in the concentrations of some hormones, testosterone, growth hormone, age related reduction in nerve cells responsible for passing signals to the muscles to initiate movement from the brain, decrease in the body’s ability to synthesize protein, inadequate intake of calories. The lack of diagnostic criteria to identify patients with Sarcopenia hinders potential management options. The treatment for Sarcopenia is Aerobic and resistance exercise, nutritional development and hormone replacement therapy. The other treatment for Sarcopenia is growth hormone supplementation and testosterone supplementation.
Over the past few decades, research has recognized the value of and has focused on aging process, impacts of Sarcopenia on physical function, mortality risk and chronic disease. The international conference and symposia on Sarcopenia research focus on biology, epidemiology of Sarcopenia, biomarkers and imaging, clinical trials and pre clinical studies, new drug development, nutrition intervention and functional assessment. The conference on Sarcopenia to exchange the information of aging, establish contacts among specialties in industry, academics, scientific networks and health authorities, build a corporative research program. The conference on Sarcopenia is a best platform for finding the best research centers dedicated to biological, social, behavior and clinical gerontology. Around 7 National symposiums and Workshops are going to be held across the globe which includes “International Conference on Sarcopenia Researchâ€, “Rheumatologyâ€, “ICFSFR†and many more.
Relevant Conferences:-
1. ICFSR-2015
2. WCO-IOF-ESCEO MILAN 2015
3. EULAR-2015
4. Rheumatology 2015
5. Nutrition and age-related muscle loss, sarcopenia and cachexia
Relevant Society and Associations:-
1. Society for Sarcopenia, Cachexia and Wasting Disorders
2. American Society For Nutrition
3. British Geriatrics Society
4. The Nutrition Society
5. SCWD
6. International Association of Gerontology and Geriatrics
7. The British Society for Rheumatology
8. Canadian Geriatrics Society
9. Nutrition Society
10. The Royal Society of Medicine
Companies:-
1. REGENERON
2. HELSINN
3. SANOFI
4. GTX
5. PLURISTEM
6. AVEO
7. NUTRICIA
8. Abbott Nutrition
9. Stealth Peptides
10. ONO Pharmaceutical co., LTD.
This page will be updated regularly.
This page was last updated on November 22, 2024
